Cite

HARVARD Citation

    Xu, G. et al. (2020). Hit-to-lead optimization and discovery of a potent, and orally bioavailable G protein coupled receptor kinase 2 (GRK2) inhibitor. Bioorganic & medicinal chemistry letters. 30 (23), p. . [Online]. 
  
Back to record